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Abstract: The use of the semiconductor quantum dots (QD) as biolabels for both ensemble and single-
molecule tracking requires the development of simple and versatile methods to target individual proteins
in a controlled manner, ideally in living cells. To address this challenge, we have prepared small and
stable QDs (QD-ND) using a surface coating based on a peptide sequence containing a tricysteine,
poly(ethylene glycol) (PEG), and an aspartic acid ligand. These QDs, with a hydrodynamic diameter
of 9 ( 1.5 nm, can selectively bind to polyhistidine-tagged (histag) proteins in vitro or in living cells.
We show that the small and monodisperse size of QD-ND allows for the formation of QD-ND/histag
protein complexes of well-defined stoichiometry and that the 1:1 QD/protein complex can be isolated
and purified by gel electrophoresis without any destabilization in the nanomolar concentration range.
We also demonstrate that QD-ND can be used to specifically label a membrane receptor with an
extracellular histag expressed in living HeLa cells. Here, cytotoxicity tests reveal that cell viability remains
high under the conditions required for cellular labeling with QD-ND. Finally, we apply QD-ND complexed
with histag end binding protein-1 (EB1), a microtubule associated protein, to single-molecule tracking
in Xenopus extracts. Specific colocalization of QD-ND/EB1 with microtubules during the mitotic spindle
formation demonstrates that QD-ND and our labeling strategy provide an efficient approach to monitor
the dynamic behavior of proteins involved in complex biological functions.
Introduction
The development of simple coupling methods to visualize,
track and eventually activate proteins using fluorescent labels
in living cells is a key step in cellular imaging.1-6 Although
fluorescent proteins have revolutionized this field, they have
shortcomings, such as rapid photobleaching of the chromophores
and the requirement of genetically modified proteins, which have
necessitated the development of alternative approaches to
chemically label proteins in live cells.3,7 In this view, fluorescent
semiconductor nanocrystal quantum dots (QDs) have received
considerable attention because of their unique optical properties,
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gies have now been described to obtain bioconjugated QD
probes, including both covalent or noncovalent interactions of
proteins or other biomolecules at the QD surface. These include
specific recognition system such as streptavidin/biotin,7,11,12
antibody-antigen recognition,13 or electrostatic interactions.14
General concerns in all these methods are the final size of the
bioconjugate,15,16 the multivalency of the conjugation, and the
preservation of protein functionality.17 Since the size of a QD
is comparable or greater than the size of many proteins, it is
technically difficult to separate QD/protein complexes with
different stoichiometries. Only recently, it was reported that gel
electrophoresis can be used to isolate QD/streptavidin/antibody
complexes with 1:1 stoichiometry.18
To target a specific site on a protein of interest, one strategy
is to introduce a small fusion tag19 such as a polyhistidine
peptide sequence (histag). This tag, commonly used for purifica-
tion, contains six (H6) or ten histidines (H10) and exhibits a
high affinity for divalent nickel (Ni2+) or zinc (Zn2+) ions.
Previously, we reported the preparation of QD-micelles bearing
a tris-nitrilotriacetic acid (trisNTA) ligand to target histag
proteins by high-affinity complexation via Ni2+ ions.20 However,
a possible limitation of these QD-micelles is that their hydro-
dynamic diameter is between 20 to 30 nm following complex-
ation with the histag protein. Since intracellular trafficking of
nanoparticles21 and their access to crowded cellular environ-
ments22 are strongly influenced by their size, it is important to
develop strategies in order to reduce the overall size of QD/
protein complexes. One effective route has been the use of
compact surface coatings which enable the direct binding of
histag proteins to exposed or accessible Zn2+ ions at the surface
of CdSe/ZnS QDs.23-26 For this purpose, PEGylated dihydro-
lipoic acid (DHLA) has been shown to facilitate the direct
interaction of histag proteins with the QD surface.18,27,28 Using
the DHLA strategy, QD/protein complexes exhibit a reduced
size (hydrodynamic diameter ∼15 nm) in comparison to QDs
with amphiphilic molecule (∼20-30 nm)29-31 or polymer-based
(∼20-30 nm)32 surface coatings.
In the present work, we report a simple alternative for labeling
individual histag proteins with QDs while maintaining a small
QD/protein complex size. We selected short peptides to stabilize
the QDs in aqueous buffers because of their good chemical
versatility as well as their higher chemical stability compared
with QD coatings formed with ester bonds.33,34 Peptides also
have the advantage that it is easy to introduce biologically active
sequences as terminal groups and they can be obtained from
commercial providers, eliminating the need for complex or time-
consuming chemical synthesis and characterization. Peptides
derived from the phytochelatin were first demonstrated to be a
very effective surface coating, yielding water-soluble QDs with
hydrodynamic diameters of ∼10-15 nm.35 We have found that
small tricysteine peptide derivatives, such as the sequence
CCCSSSD, can also interact strongly with the QD surface and
serve to form stable water-soluble QDs with a hydrodynamic
diameter of ∼10 nm.36 On the basis of these results, we prepared
small QDs based on peptide ND, composed of a tricysteine
adhesive group, a hexamer of PEG, and an aspartic acid grafted
to the terminal group. We show that for these QD-ND, the PEG
spacer effectively prevents nonspecific adsorption on cell
membranes and that the probe is nontoxic to cells under standard
experimental conditions. Furthermore, specific binding of histag
proteins is mediated by binding to Zn2+ ions directly accessible
on the QD surface and possibly enhanced by the metal-chelating
dicarboxylate acid functionality of the aspartic acid.
Through application of QD-ND, we demonstrate the ability
to label and track histag proteins both in Vitro and in living
cells. In Vitro, we show evidence from dynamic light scattering
(DLS) and fluorescence correlation spectroscopy (FCS) mea-
surements that the QD-ND/protein complex is stable, small and
can be prepared with 1:1 stoichiometry following purification
by gel electrophoresis. To show specific binding in live cells,
we targeted a membrane receptor with an extracellular poly-
histidine sequence expressed in HeLa cells. Finally, we applied
our labeling strategy to record the movement of end binding
protein-1 (EB1), a microtubule associated proteins in Xenopus
cell extracts. EB1 is a 35 kDa cytoplasmic protein known to
specifically bind to microtubules and to regulate their dynam-
ics.37 In this study, a purified histag EB1 was coupled to QD-
ND in Vitro and applied to cell extracts. We monitored QD-
ND/EB1 during the formation of the mitotic spindle, a
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microtubule-based structure essential for cell division,38 and
found that QD-ND/EB1 colocalized specifically with the spindle.
Single molecule tracking allowed us to extract the velocity
distribution of EB1 interacting with the microtubules. Variability
observed in EB1 motion might reflect the various modes of the
dynamics of the EB1/microtubule complex, illustrating the
intrinsic dynamical heterogeneity of the mitotic spindle apparatus.
Experimental Methods
Synthesis of the Peptide Ligands (See Figure 1 for Reaction
Scheme). All the reactants and solvents were purchased from Sigma
Aldrich.
Hexaethyleneglycol Mono-p-toluenesulfonate 2. Potassium
iodide KI (0.295 g, 1.78 mmol, 0.1 equiv), silver oxide Ag20 (4.95
g, 21.4 mmol, 1.2 equiv), and tosyl chloride were added to a solution
of commercial hexaethylene glycol (5.01 g, 17.8 mmol, 1 equiv)
in anhydrous CH2Cl2 (178 mL). The reaction mixture was kept at
room temperature for 18 h and then filtrated on Celite. After solvent
evaporation, the crude product was subjected to chromatography
(silica gel 60 g, elution with AcOEt/MeOH 85/15) to give the
monotosylate 2 (7.25 g, 16.6 mmol, yield 94%). 1H NMR (200
MHz, CDCl3): δ ) 7.80 (d, J ) 8 Hz, 2H), 7.34 (d, J ) 8 Hz,
2H), 4.18 (t, 2H), 3.75-3.58 (m, 22H), 2.61 (broad s, OH), 2.48
(s, 3H).
Hexaethyleneglycol Monoazide 3. 2 (7.25 g, 16.6 mmol, 1
equiv) and sodium azide were mixed in a solution of anhydrous
DMF (36 mL). The mixture was kept at reflux for 22 h under argon.
After DMF evaporation, the mixture was extracted with diethylether,
and the organic phases were washed with brine. Drying over Na2SO4
afforded 3 (4.653 g, yield 90%). 1H NMR (200 MHz, CDCl3): δ
) 3.72-3.67 (m, 22H), 3.41 (t, 2H), 2.78 (broad s, OH).
tert-Butyl 2-[Monoazide (Hexaethyleneoxy)]acetate 4. tert-
Butylbromo acetate (4.68 g, 24 mmol, 1.6 equiv), iron oxide (0.49
g, 0.2 equiv) potassium iodide (5.21 g, 1.5 equiv) were added to a
solution of 3 (4.653 g, 15 mmol, 1 equiv) in anhydrous CH2Cl2
(50 mL). The mixture was kept at room temperature for 5 days.
After filtration on Celite and solvent evaporation, the crude product
was subjected to chromatography (silica gel, eluent AcOEt/MeOH
90/10) to afford 4 (6.089 g,14.5 mmol, yield 96%). 1H NMR (200
MHz, CDCl3): δ ) 4.05 (s, 2H), 3.73 -3.69 (m, 22H), 3.41 (t,
2H), 1.51 (s, 9H).
tert-Butyl 2-[amino (Hexaethyleneoxy)]acetate 5. A suspension
of 4 (6 g, 14.5 mmol, 1 equiv) and 0.6 g of Pd/C (10% in mass) in
anhydrous CH2Cl2 (60 mL) was stirred for 45 h under reduced
pressure of dihydrogen. Filtration and solvent evaporation afforded
5 (5,09 g, 12.9 mmol, yield 90%) that was used without any further
purification. 1H NMR (300 MHz, CDCl3: δ ) 4.05 (s, 2H), 3.73
-3.69 (m, 22H), 3.95 (t, 2H),3.22 (t, 2H), 1.50 (s, 9H).
2-[Fmoc-amino (Hexaethyleneoxy)]acetic Acid 6. N-(9-Fluo-
renylmethoxycarbonyloxy)succinimide (Fmoc-OSu) (1.97 g, 5.8
mmol, 2.33 equiv) was added to a solution of 5 (0.98 g, 2.48 mmol,
1 equiv) in THF (8.6 mL) at 0 °C. The reaction mixture was kept
at room temperature for 42 h. The crude product was subjected
successively to two chromatographies (silica gel 90 g, eluent AcOEt/
hexane (50/50 and 75/25)) to give the protected amine (0.85 g,
1.82 mmol, yield 73%). 1H NMR (300 MHz, CDCl3: δ ) 7.8 (d,
2H), 7.64 (d, 2H), 7.45 (t, 2H), 7.31 (t, 2H), 5.58 (t, 1H), 4.45 (d,
2H), 4.25 (t, 1H), 4.05 (s, 2H), 3.72 -3.66 (m, 22H), 3.45 (q, 2H),
1.50 (s, 9H). The carboxylic acid function was then deprotected
with TFA to give 6, which was used as a classical protected Fmoc
peptide.
Peptide ND Synthesis. Peptides were synthesized by classical
Fmoc (N-[9-fluorenyl]methoxycarbonyl) solid-phase chemistry and
by using a commercial automatic peptide synthesizer by coupling
Fmoc-R-amino acids on preloaded Wang resin.36,39 Protected amino
acids and 6 were coupled by in situ activation with 2-(1H-
benzotriazole-1-yl)-1,1,3,3-tetramethyluronium tetrafluoroborate
(TBTU) and N-hydroxybenzotriazole (HOBt). NR-Fmoc deprotec-
tion was performed with 20% piperidine in DMF. Side-chain
deprotection and cleavage of peptides from the solid support was
performed by treatment with cleavage reagent (94.5% trifluoroacetic
acid (TFA)/2.5% water/2.5% ethanedithiol (EDT)/% triisopropyl-
silane (TIS)) for 2 h at 20 °C. Peptides were purified by reversed-
(38) Desai, A. Methods Cell Biol 1999, 61, 385. (39) Hyman, A. A. J. Cell. Sci. Suppl. 1991, 14, 125–127.
Figure 1. Synthetic route for the PEGylated peptide ND.
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phase HPLC (RP-HPLC) using a Waters semipreparative HPLC
system on an X Terra 10 µm column (300 mm × 19 mm). The
elution was performed with a gradient of aqueous 0.1% TFA (A)
and 0.08% TFA in acetonitrile (B) at a flow rate of 10 mL/min
with a photodiode array detection at 210-440 nm. The purity of
each peptide was controlled by analytical RP-HPLC on the same
instrument with an X Terra 5 µm column (250 mm × 4.6 mm)
using a linear gradient of 0.1% TFA in water and acetonitrile
containing 0.08% TFA at a flow rate of 1 mL/min. Finally, the
peptide was analyzed by electrospray spectrometry. Peptide ND:
Purity 85%, tr ) 12.48 min. HRMS [M + H]+ calcd for
C27H45N5O14S3 764.25164, found 764.2523 (1 ppm).
Peptide 7. The control peptide 7 (H2N-CCCSSSD-OH) was
prepared according to our previous described method.36 Purity 85%
tr ) 12.48 min. HRMS [M + H] + calcd for C22H37N7O13S3
704.16898, found 704.1688 (1 ppm).
Peptide Functionalization of QDs. Commercial core/shell CdSe/
ZnS QDs (Evidots, Evident Technology, λem ) 545 or 605 nm)
were precipitated from initial toluene solution with methanol and
dried under vacuum and then redispersed in a pyridine solution.
Peptides ND or 7 were dissolved in anhydrous 99.8% dimethyl
sulfoxide (DMSO), at a concentration between 10 and 30 mM. The
QDs in pyridine and the peptide solution in DMSO were mixed
together. After addition of tetramethylammonium hydroxide, ag-
gregates of fluorescent QD-peptide were isolated by centrifugation
during 30 min at 15000g. After removing the supernatant, the QDs
were dried for 2 h and then redispersed in water. To remove the
aggregated nanocrystals, this solution was ultracentrifuged at
100000g during 30 min on a 50% sucrose cushion. The resulting
sample was passed through a G25 spin column and dialyzed against
pure water to remove sucrose and the excess of free peptide. Before
using, the QD-peptide solution was filtered through a 0.22 µm
Millipore filter (Millex HV, Sigma-Aldrich).
EB1 Expression and Purification. Full-length H6-EB1 was
expressed in BL21-PlysS cells (Novagen) and purified on nickel-
agarose beads.40 After dialysis against a sodium phosphate buffer,
the proteins were flash frozen and stored at -80 °C in aliquots.
Dynamic Light-Scattering (DLS) and Fluorescence Correla-
tion Spectroscopy (FCS). The mean hydrodynamic diameters were
obtained from a Nanosizer ZEN3600 (Malvern Instruments) DLS
spectrometer (angle 90° at 25 °C). All samples were filtered through
0.22 µm Millipore filter. FCS measurements were performed on a
home-built microscope equipped with an Olympus 60X water
immersion objective (UPlan Apo, NA 1.2). Two-photon excitation
(200 fs, 76 kHz, 750 nm excitation) was provided by a mode-locked
Ti-Sapphire laser (Mira, Coherent). The incident power at the
sample was measured with a Lasermate powermeter (Coherent).
The fluorescence photons were collected through filters (AHF
Analysentechnik) and optical fibers (FG200LCR multimode fiber,
Thorlabs) and detected with avalanche photodiodes (SPCM-AQR-
14, Perkin-Elmer) coupled to an ALV-6000 correlator (ALV
GmbH). The geometrical characteristics of the focal point were
determined using a fluorescein solution of known concentration (50
nM in 0.1 M NaOH). FCS measurements were performed on
aqueous QD solutions in the nanomolar range at 20 °C. Autocor-
relation curves were well adjusted, assuming a single freely
diffusing species in solution. In the case of two-photon excitation,
the diffusion time τD through the beam waist of size ω can be linked
to the hydrodynamic radius R of the diffusing species using the
Stokes-Einstein relation by: τD ) 3πηRω2/4kT where η is the
viscosity, T the temperature and k the Boltzmann constant.
Electrophoresis and Protein Coupling. QD-ND (200nM) was
preloaded with Ni2+ (50 µM) for 15 min, and then incubated with
various molar ratios of histag EB1 during 1 h. Gel electrophoresis
of the different QD-ND/EB1 ratios was performed on a 0.5%
agarose gel in in HEPES buffer (pH 7.5) under an applied voltage
of 100 V for 30 min.
Photophysical Properties. UV-vis spectra of QDs were
performed on a Cary 100 UV-vis spectrophotometer (Varian). The
QD diameters were evaluated from the maximum absorbance of
the excitonic peak, and the extinction coefficient at 350 nm was
calculated according to the literature (for QDs with emission at
605 nm, ε ) 105 cm-1 ·mol-1). Fluorescence spectra were measured
on a Spectrolog 3 (Horiba Jobin Yvon) fluorimeter.41,42
Quartz Crystal Microbalance. The quartz crystal microbalance
(QCM-D) experiments were performed on a Q-Sense D 300
apparatus (Q-Sense AB) by monitoring the resonance frequencies
of the gold-coated crystal at four different frequencies (5, 15, 25,
and 35 MHz). These data give, in principle, information about the
adsorption process as well as the mechanical properties of the
deposited film.43,44 At the start, the crystal was put into contact
with a buffer solution (Tris-borate-NaCl: TrisBase 0.89 M, boric
acid 0.89 M, NaCl 0.20 M) for 10 min. Next, a 0.5 mg/mL peptide
ND solution was injected and left 50 min in contact with the sensor
before three successive rinsing steps with the buffer. A solution of
NiCl2 (1.5 mM) was then injected followed by EB1 solution (0.07
mg/mL in buffer solution). After stabilization of the signal and a
rinsing step with the buffer, EDTA solution (2 mM) was injected.
Cellular Cytotoxicity MTT Assay. HeLa cell culture was
performed in Dulbecco’s modified Eagle’s medium (DMEM)
supplemented with 10% of fetal calf serum, 100 U/mL penicillin,
100 µg/mL streptomycin at 37 °C/5% CO2. The HeLa cells were
seeded in 96 multiwell plates (500 cells per well, 100 µL) 24 h
before adding the QDs. Then after growth medium removal,
appropriate concentrations of QD-ND (filtered 0.22 µm) were added
to each well. The typical protocol for MTT assay was as follows:
A 5 mg/mL aqueous solution of MTT (methylthiazolyldiphenyl-
tetrazolium bromide, Sigma Aldrich) was added to HeLa cells (10
µL). After 4 h of incubation at 37 °C/5% CO2, the plates were
centrifuged (5 min, 1000 rpm). After medium removal and addition
of DMSO (150 µL), the plates were stirred until complete
dissolution of the purple formazan crystals. Finally, the absorbance
at 540 nm was measured by a UV-vis plate reader (Labsystems
Multiscan RC) driven by Biolise software. The absorbance was
normalized using absorbance of control cells grown in nonmodified
medium.
HeLa Cell Labeling. HeLa cells were transfected 24 h before
labeling with the gene expressing the membrane protein H10-CFP-
TM, a transmembrane domain of platelet-derived growth factor
receptor7 as previously reported.20 Cell labeling was performed by
placing coverslips on a heating block at 37 °C. Cells were labeled
with 20 nM QD-ND by incubation in PBS for 10 min followed by
repeated washing with PBS. HeLa cells were imaged at room
temperature in OptiMem on an inverted wide-field epifluorescence
microscope (Olympus, IX70) equipped with a 60× oil objective
(NA 1.45, Olympus). Fluorophores were excited with a broad-
spectrum mercury lamp source. Images were acquired using a back-
illuminated CCD camera (Micromax 512EBFT, Roper Scientific)
and MetaView software (Universal Imaging). H10-CFP-TM was
imaged through a CFP filter set (excitation: 440 ( 10 nm, dichroic:
455 nm, emission: 480 ( 20 nm). QD-ND was imaged through a
custom filter set (excitation: 420 ( 10 nm, dichroic: 470 nm,
emission: 595 ( 10 nm).
QD Monitoring of Microtubules Self-Organization and
Spindle Formation. Cytostatic-factor-arrested Xenopus laeVis egg
extracts were prepared as previously described.38 Tubulins, labeled
(40) Tirnauer, J. S.; Grego, S.; Salmon, E. D.; Mitchison, T. J. Mol. Biol.
Cell 2002, 13 (10), 3614–3626.
(41) Leatherdale, C. A.; Woo, W. K.; Mikulec, F. V.; Bawendi, M. G. J.
Phys. Chem. B 2002, 106 (31), 7619–7622.
(42) Yu, W. W.; Qu, L.; Guo, W.; Peng, X. Chem. Mater. 2003, 15 (14),
2854–2860.
(43) Marx, K. A. Biomacromolecules 2003, 4 (5), 1099–1120.
(44) Ho¨o¨k, F.; Vo¨ro¨s, J.; Rodahl, M.; Kurrat, R.; Boni, P.; Ramsden, J. J.;
Textor, M.; Spencer, N. D.; Tengvall, P.; Gold, J.; Kasemo, B. Colloids
Surf., B 2002, 24, 155–170.
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with X-Rhodamine (Molecular Probes) were prepared as previously
described.39 The molar ratio between QD-ND and EB1 was 1:6. A
solution of QD-ND/EB1 complex solution in the nanomolar range
was incubated 15 min after the beginning of the spindle assembly
process. Fluorescence imaging of microtubule spindles was per-
formed using an IX81 (Olympus) equipped with either a X60 (Plan
Apo, NA 1.42) or a X100 (Plan Apo, NA 1.4) objective, and an
EM-CCD (C9102, Hamamatsu). Image analyses were performed
using Image J Software (Scion Image) and Simple PCI software.
The mean velocity was calculated from the image sequence of the
individual QD-ND/EB1 collected during 20 s (N ) 87 events). The
motion of individual QDs was acquired with an integration time
of 100-400 ms per frame.
Results and Discussion
For the purpose of stabilizing QDs in aqueous buffer and
enabling the conjugation of histag proteins, the short PEGylated
peptide ND was synthesized according to the scheme presented
in Figure 1. At the N-terminal, a tricysteine serves as an adhesive
sequence designed to bind to the QD surface. An aspartic acid,
which is negatively charged at basic pH, was grafted at the
C-terminal to provide charge stabilization of the colloidal QDs
in a variety of common buffers and at different pHs (see Figure
S1 in Supporting Information). In addition, the aspartic acid
was selected because of its expected ability to chelate metal
ions and enhance the binding of histag proteins. Between the
tricysteine and aspartic acid, a hexamer of PEG was introduced
as a spacer to reduce nonspecific interactions and improve
solubility. To obtain this compound, the PEGylated amino acid
6 was synthesized in several steps. Hexaethylene glycol 1 was
first activated as the monotosylate 2 in the presence of a silver
oxide catalysis and then converted into hexaethyleneoxy mono
azide 3. After substitution of the free terminal alcohol with the
tert-butylbromo acetate and azide reduction of 4, the bifunctional
amino and protected carboxylic acid derivative 5 was obtained.
The amino group was then protected with Fmoc succinimide.
After deprotection of the carboxylic acid function with TFA,
the resulted PEGylated amino acid 6 was first coupled to an
aspartic acid preloaded Wang resin according to classical Fmoc
(N-[9-fluorenyl] methoxycarbonyl) solid-phase chemistry. Three
cysteines were successively coupled by using a TBTU/HOBt
activation. Finally after cleavage and deprotection, the peptide
ND was obtained. To form a control peptide without the PEG
spacer (peptide 7), the compound 6 was replaced by triserine
spacer (Figure 2a).
To test the ability of the terminal aspartic acid in peptide
ND to bind histag proteins via Ni2+ chelation, a surface-based
assay was performed using a quartz crystal microbalance (QCM)
and the protein histag EB1. The peptide ND was deposited on
the gold-coated quartz microbalance via the strong interaction
between cysteines and the gold surface. The adsorption and
desorption of the histag EB1 proteins to the immobilized ND
peptide in the presence or absence of Ni2+ ions was monitored
(Figure S2 and Table S1 in Supporting Information). After
preloading the ND peptide surface with Ni2+ ions, adsorption
of the histag EB1 was enhanced by more than 3-fold compared
to that in the absence of Ni2+ ions (Table S1 in Supporting
Information). The addition of an EDTA competitor induced a
desorption of about 46% of the adsorbed protein, indicating that
a large fraction of the histag EB1 was bound through the Ni2+-
loaded aspartic acid of the ND peptide.
Figure 2. (a) Chemical structures of peptide ND and peptide 7. (b) (left) DLS volume distribution and (right) agarose gel electrophoresis of QD-ND before
(1) and after (2) incubation with 50 µM NiCl2 and the corresponding absorbance/emission spectra of QD-ND before (solid line) and after incubation with
NiCl2 (dashed line).
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Commercial semiconductor CdSe/ZnS QDs (λem ) 605 nm)
were functionalized with the peptide ND or 7 according to a
previously described method36 (see Figure 2a) based on ligand
exchange between the initial trioctylphosphine oxide ligands
of the hydrophobic QDs and the peptides.35 Water-soluble QD-
ND exhibited a hydrodynamic diameter of 9 nm ((1.5 nm),
determined by DLS and FCS measurements (see Table 1) and
presented a high colloidal stability (over several months) in
common buffers. During gel electrophoresis, the QDs migrated
in a narrow band toward the positive electrode, which is
consistent with their expected net negative charge (Figure 2b).
The optical properties of the QDs were not altered after
functionalization with the peptides, as shown from absorbance
and fluorescence spectra (Figure 2b).36 In addition, the emission
intensity was found to be stable between 6 and 12 and weakly
affected until the pH reached 5 (see Figure S1 in Supporting
Information). A strong quenching was then observed for acidic
pHs (lower than 5). Therefore, the QD-NDs were found to be
stable between pH 5 and 12. The effect of loading QD-ND with
50 µM Ni2+ was also minimal (Figure 2b), after optimizing the
concentration and type of divalent cation (see Figure S3 in
Supporting Information). The measured fluorescence quantum
yield of the QD-ND was found to be around 25% in water,
which is an improvement over other peptide-based surface
coatings.35
Next, we tested the effect of the PEG spacer on nonspecific
cellular interactions of the peptide-stabilized QDs. We monitored
the adhesion of PEGylated QD-ND and non-PEGylated QD-7
toward living HeLa cells following incubation for 10 min and
analysis by fluorescence microscopy (Figure 3). Nonspecific
adsorption of the QD-7 on cell surface was present in high
levels, indicated by the presence of QD fluorescence on the cell
membranes, but was nearly completely inhibited by replacing
the triserine spacer in 7 by the hexamer of PEG (case of QD-
ND). Consequently, all the following experiments were per-
formed with QD-ND.
The affinity of the QD-ND for histag proteins was then
investigated in solution by following the interaction with DLS
and FCS (Figure S4 in Supporting Information). A systematic
increase in hydrodynamic diameter was observed for QD-ND,
following incubation with increasing amounts of histag EB1
(Table 1). Considering the respective geometry of QD-ND and
the EB1, the 10 nm increase in diameter observed for high ratios
of the protein is in good agreement with the binding and steric
saturation of the EB1 on the QD surface.
To provide further evidence of the conjugation between the
QD-ND and the histag EB1, a titration of QD-ND with the
protein was followed by gel electrophoresis. The addition of
histag EB1 at various ratios to the QD-ND samples resulted in
a systematic change in the QD migration patterns observed
following electrophoresis (Figure 4a and Figure S5 in Supporting
Information). QD-ND without EB1 migrated in a narrow, single
band toward the positive electrode. However, in the QD-ND
samples incubated with low ratios of EB1, discrete bands formed
in the gel corresponding to different stoichiometries of the QD-
ND/EB1 complex (Figure 4a). At higher ratios of the protein,
the sample merged again to a single band because of the steric
saturation of the QD surface with EB1.30 On the basis of the
ability to resolve these discrete bands in the gel, QD-ND
containing exactly 1, 2, and 3 copies of EB1 were isolated and
purified by gel extraction. The temporal stability of the isolated
complexes was high, because reanalysis of the purified 1:1 QD-
ND/EB1 after several hours of storage showed that the complex
maintained the expected position in the gel with respect to the
unconjugated QD-ND (Figure 4b). Thus, small and stable QD/
protein complexes with defined stoichiometry could be prepared
based on QD-ND.
In control experiments using gel electrophoresis, it was found
that binding occurs between histag EB1 proteins and QD-ND
without Ni2+ preloading of QD-ND (Figure S6 in Supporting
Information). This suggests that there are multiple binding
mechanisms between the histag sequence of the protein and QD-
ND. The predominant mechanism is likely binding of the histag
protein directly to Zn2+ ions on the ZnS shell of the QD, owing
to the highly compact nature of the peptide coating. Coinci-
dently, this is the route of histag binding to QDs with similarly
compact DHLA coatings.23,45 As suggested by our QCM surface
assay, a secondary histag binding mechanism can occur through
the aspartic acid chelated to Ni2+ ions, which may enhance the
affinity of QD-ND to the histag.
To validate the use of the QD-ND in a biological system,
we chose to probe the efficiency of our protein targeting system
with living HeLa cells expressing a histag protein. As a first
step, we designed an assay to determine the cytotoxicty of QD-
ND. We used the colorimetric MTT assay to monitor HeLa cell
viability as a function of both the QD-ND concentration and
incubation time (Figure S7 in Supporting Information). No
significant effect on cell viability was observed after one hour
of incubation in the presence of QD-ND for concentrations
ranging from 1 to 100 nM. A decrease in cell viability was
seen only for incubation times exceeding 24 h. In this case,
relative cell viability decreased to 60% and 40% for QD-ND
concentrations of 75 nM and 100 nM, respectively. Similar
results were observed when the QD-ND were preloaded with
(45) Pons, T.; Medintz, I. L.; Wang, X.; English, D. S.; Mattoussi, H. J. Am.
Chem. Soc. 2006, 128 (47), 15324–15331.
Table 1. Hydrodynamic Diameters of QD-ND before and after
Incubation with 1 and 10 equiv of Histag EB1 Protein, As
Measured by Fluorescence Correlation Spectroscopy (FCS) and
Dynamic Light Scattering (DLS)
mean hydrodynamic
diameters obtained by 0 nEB1/nQD 1 nEB1/nQD 10 nEB1/nQD
FCS 13 ( 2 nm 16 ( 2 nm 24 ( 3 nm
DLS 9 ( 1.5 nm 14 ( 2.5 nm 20 ( 4 nm
Figure 3. Fluorescence (top row) and bright field (bottom row) optical
microscopy images of HeLa cells after a 10 min incubation with 100 nM
of QD-ND (a and c) and QD-7 (b and d) followed by extensive washing.
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50 µM NiCl2 before incubation in presence of the cells (see
Figure S8 in Supporting Information). On the basis of these
observations, QD-ND can be used for cellular labeling in
nanomolar concentrations and for incubation periods up to one
hour without affecting the cell viability.
Then, we investigated whether QD-ND can be used to target
a specific protein on the membrane of the HeLa cells. HeLa
cells were first transfected with the gene expressing the
membrane protein H10-CFP-TM, having the transmembranar
domain of platelet-derived growth factor receptor.7 The extra-
cellular domain of the H10-CFP-TM includes a histag and a
cyan fluorescent protein (CFP), which is used to identify cells
expressing the protein. To target the H10-CFP-TM, 20 nM QD-
ND was incubated with the cells for 10 min following by
extensive washing with fresh medium. The cells were then
examined by fluorescence microscopy. In the CFP channel,
approximately 50% of the cells could be identified as expressing
H10-CFP-TM (Figure 5a), while cells not expressing the protein
were only visible under bright field illumination (Figure 5b).
In the QD-ND channel, we observed QD-ND to be colocalized
only on cells positive for H10-CFP-TM (Figure 5c and d). The
diffusive movements of individual QD-ND bound to the H10-
CFP-TM could be observed as shown in Movie S1 (see
Supporting Information). In addition, the QD-ND labeling of
H10-CFP-TM was eliminated after the addition of free imida-
zole, a competitor of the histag (Figure 5e). Combined, these
observations demonstrate that the interaction between the cells
and QD-ND occurs via the specific histag sequence of the H10-
CFP-TM protein. The same experiment performed in the
absence of Ni2+ loading also led to specific labeling of the H10-
CFP-TM protein with QD-ND (Figure 5f-i), reinforcing our
in Vitro results that binding of histag proteins occurs predomi-
nantly at the Zn2+ surface of the QD.
To demonstrate that EB1 coupled to QD-ND remains
biologically active, we monitored the interaction of the QD-
ND/EB1 complex with microtubules during mitotic spindle
formation. QD-ND/EB1 was prepared by mixing histag EB1
and QD-ND (using QD with an emission at 545 nm) at a ratio
of 6:1. We used Xenopus cell extracts, a system known to
recapitulate key events of the cell cycle38 and well-suited to
monitor microtubule morphogenesis dynamics. The absence of
membrane boundaries in the cell extracts allows for direct
Figure 4. (a) Separation of QD-ND/EB1 complexes by 0.5% agarose gel electrophoresis. QD-ND loaded with Ni2+ was incubated with increasing concentrations
of histag EB1 protein (n ) 1 equivalent of QD-ND calculated from UV absorbance) for 1 h prior to loading and running the gel. (b) Gels of the QD-ND/EB1
complex before and after gel extraction and purification of the 1:1 QD-ND:EB1 stoichiometry.
Figure 5. Fluorescence and bright field optical microscopy images of the HeLa cells expressing a transmembrane receptor incorporating an extracellular
histag and CFP (H10-CFP-TM). Cells were incubated for 10 min with 20 nM of QD-ND either in the presence (top row) or absence (bottom row) of Ni2+
loading. (a and f) CFP channel (red), showing the presence of cells expressing H10-CFP-TM. (b and g) Brightfield images of all the cells in the field of view.
(c and h) QD-ND channel (green), showing the binding of QD-ND to cells expressing the H10-CFP-TM. (d and i) Superposition of the CFP and QD
channels, showing the colocalization of the CFP and QD-ND signals. (e) QD-ND channel, after treatment of the cells with 100 mM imidazole showing the
removal of the QD-ND from the cell surface.
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delivery of the QD-ND/EB1 in the cytosol without requiring
endocytosis or microinjection. Rhodamine-labeled tubulin was
initially supplemented to cell extracts to visualize microtubule
filaments. The mitotic spindle self-organized to reach a steady-
state structure within 30 to 45 min and the QD-ND/EB1 complex
was applied 15 min after the initiation of the assembly. First,
we performed static time-point measurements of samples at 30
and 45 min. We found that microtubule bundles and QD-ND/
EB1 colocalized along microtubule based-structures (Figure
6a-c). The interactions between QD-ND/EB1 and microtubules
were specific, as no colocalization between QDs and microtubule
structures was observed when cell extracts were similarly treated
with QD-ND lacking EB1 or QD-ND complexed with histag
maltose binding protein (MBP), a protein which does not
associate with microtubules (a,b and c,d, respectively, of Figure
S9 in Supporting Information).
Next, time-lapse experiments were performed in order to
monitor the QD-ND/EB1 dynamics within the microtubule-
based structures. As shown in Movie S2 (see Supporting
Information), most of the QD-ND/EB1 complexes that colo-
calize with the microtubule-based structures are dynamic. In
Figure 6b and in Movie S3 (see Supporting Information), we
report a time sequence of an individual QD-ND/EB1 complex
performing a run of 13 µm within 30 s along a growing
microtubule filament. In another example highlighted in Figure
6c, the QD-ND/EB1 dynamics switched between fast motion
and slower motion regimes. As EB1 binds preferentially to the
plus-end of microtubules,37 the QD-ND/EB1 motion we ob-
served reflects the dynamics of microtubule growth in the mitotic
spindle.
The velocity histogram of individual events illustrates the
heterogeneity of the dynamic QD-ND/EB1 behavior within the
spindle structures (Figure 6d). Most dynamic events exhibit a
mean velocity within the window of 2 and 5 µm/min. Recently,
single-molecule experiments performed with the yeast homo-
logue of EB1 in a reconstituted system reported velocities
between 2.5 to 10 µm/min,46 and tracking of clusters of EB1-
alexa594 within mitotic spindles reported an average velocity
of 11 µm/min.47 This variability observed in QD-ND/EB1
behavior might correlate with the dynamic properties of the
mitotic spindle apparatus. For example, microtubules undergo
rapid assembly, disassembly, and constant transport, providing
Figure 6. Specific targeting and tracking of QD-ND/EB1 on spindle structures following incubation of the QDs (λem ) 545 nm) with cell extracts. (a)
Rhodamine-labeled spindle structure (red channel) with QD-ND/EB1 (green channel) and the overlay of the two channels (shown in yellow). (b) Temporal
image sequence (5 s/frame) of a single QD-ND/EB1 moving on a microtubule (see arrow). (c) Temporal sequence of a single QD-ND/EB1 (5 s/frame) on
a microtubule exhibiting a switch between a fast and slow movement. (d) Mean velocity histogram extracted from a collection of individual QD-ND/EB1
moving on the spindle structures (3 independent experiments, 3 structures).
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multiple mechanisms to influence the dynamics. Both growing
microtubules and rapid treadmilling of the tubulin dimers within
microtubule filaments drive the observed QD-ND/EB1 dynam-
ics. In addition, processive molecular motors may transport the
QD-ND/EB1 complexes along microtubule filaments. These
different modes of motion all reflect the complex and hetero-
geneous nature of the mitotic spindle assembly and maintenance
cycles.
Conclusion
PEGylated peptides were found to stabilize CdSe/ZnS QDs
in aqueous solution and to facilitate direct conjugation of
polyhistidine-appended proteins with a controlled stoichiometry.
This commercially available peptide offers an alternative way
to label and target proteins with QD probes and can be extended
to gold nanoparticles using the same functionalization methods.
The obtained QD-ND-protein complexes were found to be very
stable and of small size, which is highly desirable for cellular
labeling. Additional advantages of this labeling approach are
the simplicity of the conjugation to histag proteins, the control
over the stoichiometry, and the reversibility of the binding in
presence of competitors. One potential drawback of the method
is the requirement of genetic engineering to introduce a
polyhistidine sequence into the protein of interest. However,
this has become routine practice in most laboratories, as the
histag is now a standard method for protein purification.
Our QD-ND probe and labeling strategy was successfully
applied to two different biological systems. First, we targeted a
histag protein tethered to the external membrane of living cells.
Then, we spatially and temporally monitored a microtububle-
associated protein, EB1, within mitotic spindles assembled in
cell extracts. Both systems demonstrate the ability of QD-ND
for single-molecule tracking over long time scales not accessible
by standard organic fluorescent labels. The possibility to target
and study a variety of histag proteins, one at a time, should
allow us to further understand how complex biological structures
emerge from single-molecule events and maintain their integrity
despite the transient and rapid turnover of their building blocks.
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